Have science, can't travel

Mohammad Sajid Credit: Courtesy of UCSF" />Mohammad Sajid Credit: Courtesy of UCSF Last July, a British biologist strolled into the US embassy in London to get his temporary (J-1) visa stamped so he could return to his California lab. He wasn't worried, even after he learned he needed to undergo a background check. The last time he left London for the United States, a mere 15 months earlier, a background check delayed him for six months. He was told any later checks would be mu

Written byEdyta Zielinska
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Last July, a British biologist strolled into the US embassy in London to get his temporary (J-1) visa stamped so he could return to his California lab. He wasn't worried, even after he learned he needed to undergo a background check. The last time he left London for the United States, a mere 15 months earlier, a background check delayed him for six months. He was told any later checks would be much quicker, so he had confidently returned to London for a wedding and scientific conference. The second round should take a few weeks, he was told. So he waited. And waited. The weeks turned into months; his experiments went stale, his colleagues struggled to work around his absence, and another team scooped him by publishing its findings on one of his projects.

Eight months later, Mohammad Sajid was finally cleared to return to the United States. The two ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies